#gene editing

[ follow ]
#gene-editing

Gene editing's next big targets

Gene editing advances focus on fighting cancers and common diseases, exploring aging, editing RNA.

CRISPR genome-editing grows up: advanced therapies head for the clinic

Gene-editing therapies like Casgevy show long-lasting benefits for blood disorders but face challenges in accessibility due to complexity and cost.

No CRISPR: oddball 'jumping gene' enzyme edits genomes without breaking DNA

A molecular oddity in bacteria could lead to precise genome redesign through jumping genes, surpassing CRISPR limitations.

A Novel Discovery Hints At Why We Stop Producing New Brain Cells - And What We Can Do About It

Neural stem cells' decline with age can be linked to glucose levels, highlighting a potential pathway for combating cognitive decline.

Designer Babies Are Here - So Why Aren't We Talking About It?

Scientists often overlook the societal implications of their research due to a lack of training and incentives.

Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing

CRISPR technology offers transformative potential for medicine and agriculture but raises significant ethical and societal concerns.

Gene editing's next big targets

Gene editing advances focus on fighting cancers and common diseases, exploring aging, editing RNA.

CRISPR genome-editing grows up: advanced therapies head for the clinic

Gene-editing therapies like Casgevy show long-lasting benefits for blood disorders but face challenges in accessibility due to complexity and cost.

No CRISPR: oddball 'jumping gene' enzyme edits genomes without breaking DNA

A molecular oddity in bacteria could lead to precise genome redesign through jumping genes, surpassing CRISPR limitations.

A Novel Discovery Hints At Why We Stop Producing New Brain Cells - And What We Can Do About It

Neural stem cells' decline with age can be linked to glucose levels, highlighting a potential pathway for combating cognitive decline.

Designer Babies Are Here - So Why Aren't We Talking About It?

Scientists often overlook the societal implications of their research due to a lack of training and incentives.

Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing

CRISPR technology offers transformative potential for medicine and agriculture but raises significant ethical and societal concerns.
moregene-editing

FDA approves first gene-editing treatments for human illness

The FDA has approved the first gene-editing treatments for sickle cell disease, marking a milestone in the field of gene-editing.
The treatments have the potential to provide more targeted and effective treatments for rare diseases with limited current options.

F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR

The Food and Drug Administration has approved the first gene editing therapy and conventional gene therapy for sickle cell disease.
Obstacles to treatment include limited access to authorized medical centers, individualized procedures, and high costs.

The CRISPR Era Is Here

Gene-editing technology CRISPR has successfully treated a patient with sickle-cell disease, providing hope for future treatments.
The treatment resulted in the patient living virtually symptom-free, with 29 out of 30 eligible patients experiencing zero pain crises after treatment.
[ Load more ]